Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Hampel

Showing results (171-180 of 190) with videos related to

Pageof 19
Sort By:
Neurology|December 12, 2007
Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCIM Ewers, K Buerger, S J Teipel, et al.
Neurology|January 13, 2012
Biomarker validation of a cued recall memory deficit in prodromal Alzheimer diseaseM Wagner, S Wolf, F M Reischies, et al.
The Journal of Nutrition, Health & Aging|March 6, 2009
Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessmentK Blennow, G De Meyer, O Hansson, et al.
The Journal of Nutrition, Health & Aging|April 14, 2012
Alzheimer's disease therapeutic trials: EU/US Task Force report on recruitment, retention, and methodologyB Vellas, H Hampel, M E Rougé-Bugat, et al.
The Journal of Prevention of Alzheimer'S Disease|December 20, 2017
EU./U.S. CTAD Task Force on Alzheimer's Trial PopulationsB Vellas, C Sampaio, R Bateman, et al.
The Journal of Prevention of Alzheimer'S Disease|December 7, 2017
Registries and Cohorts to Accelerate Early Phase Alzheimer's Trials. A Report from the E.U./U.S. Clinical Trials in Alzheimer's Disease Task ForceP Aisen, J Touchon, S Andrieu, et al.
Experimental Neurology|August 12, 2009
Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexingP Lewczuk, J Kornhuber, E Vanmechelen, et al.
Annals of Clinical Biochemistry|April 4, 2009
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's diseaseN A Verwey, W M van der Flier, K Blennow, et al.
Neurobiology of Aging|August 30, 2005
Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairmentM J de Leon, S DeSanti, R Zinkowski, et al.
Dementia and Geriatric Cognitive Disorders|September 29, 2011
Regional differences in effects of APOE ε4 on cognitive impairment in non-demented subjectsJ Norberg, C Graff, O Almkvist, et al.
Pageof 19

Showing results (171-180 of 190) with videos related to

Sort By:
Pageof 19
Neurology|December 12, 2007
Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCIM Ewers, K Buerger, S J Teipel, et al.
Neurology|January 13, 2012
Biomarker validation of a cued recall memory deficit in prodromal Alzheimer diseaseM Wagner, S Wolf, F M Reischies, et al.
The Journal of Nutrition, Health & Aging|March 6, 2009
Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessmentK Blennow, G De Meyer, O Hansson, et al.
The Journal of Nutrition, Health & Aging|April 14, 2012
Alzheimer's disease therapeutic trials: EU/US Task Force report on recruitment, retention, and methodologyB Vellas, H Hampel, M E Rougé-Bugat, et al.
The Journal of Prevention of Alzheimer'S Disease|December 20, 2017
EU./U.S. CTAD Task Force on Alzheimer's Trial PopulationsB Vellas, C Sampaio, R Bateman, et al.
The Journal of Prevention of Alzheimer'S Disease|December 7, 2017
Registries and Cohorts to Accelerate Early Phase Alzheimer's Trials. A Report from the E.U./U.S. Clinical Trials in Alzheimer's Disease Task ForceP Aisen, J Touchon, S Andrieu, et al.
Experimental Neurology|August 12, 2009
Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexingP Lewczuk, J Kornhuber, E Vanmechelen, et al.
Annals of Clinical Biochemistry|April 4, 2009
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's diseaseN A Verwey, W M van der Flier, K Blennow, et al.
Neurobiology of Aging|August 30, 2005
Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairmentM J de Leon, S DeSanti, R Zinkowski, et al.
Dementia and Geriatric Cognitive Disorders|September 29, 2011
Regional differences in effects of APOE ε4 on cognitive impairment in non-demented subjectsJ Norberg, C Graff, O Almkvist, et al.
Pageof 19